EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The mechanobiology of fibroblast activation in disease

Yeji Chang iD, Jia Wen Nicole Lee iD, Andrew W Holle iD

APL Bioengineering · 01.06.2025 · 9 (2)

DOI: 10.1063/5.0272393 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift APL Bioengineering, online erschienen am 18.06.2025. Verfasst von Yeji Chang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Mechanobiology Institute, National University of Singapore, 117411 Singapore, Singapore. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Mechanobiology Institute, Singapore, National Research Foundation Singapore.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblasts play crucial roles in wound healing, cancer, and fibrosis. Many aspects of these roles are driven by the process known as fibroblast activation. The generally accepted definition of fibroblast activation is the transition from a quiescent state to a state in which fibroblasts participate in a number of active processes, including extracellular matrix (ECM) production and remodeling, elevated contractility, and enhanced migratory capacity, although there is no universal consensus on what exactly constitutes “activation.” Interestingly, the time scale of activation is not consistent across tissues and disease states; some fibroblasts quickly return to quiescence after activation (e.g., in wound healing), others undergo apoptosis, while a subset become persistently activated. This activation, both acute and persistent, is inherently a mechanical process, given the increase in ECM production and remodeling and the enhanced traction force generation. Thus, there exists a dynamic reciprocity, or cell-ECM feedback, in which activated fibroblasts produce a mechanical microenvironment that in turn supports persistent activation. This has a wide variety of implications for disease, most notably fibrosis and cancer, as the fibroblasts that become persistently activated in connection with these conditions can contribute to disease state progression. Like other mechanosensitive processes, this mechanically induced persistent fibroblast activation is driven by a number of mechanotransduction signaling pathways. Thus, an opportunity exists in which the mechanosensitive underpinning of fibroblast activation can be leveraged to improve clinical outcomes. Here, we highlight these opportunities and make a call to the field to consider the mechanosensitive pathways governing fibroblast activation as an important frontier in mechanomedicine.

Autor:innen und Institutionen

  • Mechanobiology Institute, National University of Singapore, 117411 Singapore, Singapore.

ORCID-Profile: Yeji Chang, Jia Wen Nicole Lee, Andrew W Holle

Förderung

  • Mechanobiology Institute, Singapore
  • National Research Foundation Singapore

Zitieren

APA

Chang, Y., Lee, J. W. N., & Holle, A. W. (2025). The mechanobiology of fibroblast activation in disease. APL Bioengineering, 9(2). https://doi.org/10.1063/5.0272393

Vancouver

Chang Y, Lee JWN, Holle AW. The mechanobiology of fibroblast activation in disease. APL Bioengineering. 2025;9(2). doi:10.1063/5.0272393

BibTeX
@article{Chang2025,
  author = {Chang, Yeji and Lee, Jia Wen Nicole and Holle, Andrew W},
  title = {The mechanobiology of fibroblast activation in disease},
  journal = {APL Bioengineering},
  year = {2025},
  volume = {9},
  number = {2},
  doi = {10.1063/5.0272393}
}
Kostenlos starten →